Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study
Conditions:   Wheezing;   Asthma in Children Intervention:   Drug: Soy isoflavone Sponsors:   Rajesh Kumar;   Northwestern University;   University of South Florida;   University of Colorado, Denver;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2022 Category: Research Source Type: clinical trials

Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study
Conditions:   Wheezing;   Asthma in Children Interventions:   Drug: Soy isoflavone;   Drug: matching placebo Sponsors:   Rajesh Kumar;   Northwestern University;   University of South Florida;   University of Colorado, Denver;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2022 Category: Research Source Type: clinical trials

Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study
Conditions:   Wheezing;   Asthma in Children Intervention:   Drug: Soy isoflavone Sponsors:   Rajesh Kumar;   Northwestern University;   University of South Florida;   University of Colorado, Denver;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2022 Category: Research Source Type: clinical trials

Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study
Conditions:   Wheezing;   Asthma in Children Interventions:   Drug: Soy isoflavone;   Drug: matching placebo Sponsors:   Rajesh Kumar;   Northwestern University;   University of South Florida;   University of Colorado, Denver;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2022 Category: Research Source Type: clinical trials

Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study
Conditions:   Wheezing;   Asthma in Children Intervention:   Drug: Soy isoflavone Sponsors:   Rajesh Kumar;   Northwestern University;   University of South Florida;   University of Colorado, Denver;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2022 Category: Research Source Type: clinical trials

Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study
Conditions:   Wheezing;   Asthma in Children Interventions:   Drug: Soy isoflavone;   Drug: matching placebo Sponsors:   Rajesh Kumar;   Northwestern University;   University of South Florida;   University of Colorado, Denver;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2022 Category: Research Source Type: clinical trials

Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study
Conditions:   Wheezing;   Asthma in Children Intervention:   Drug: Soy isoflavone Sponsors:   Rajesh Kumar;   Northwestern University;   University of South Florida;   University of Colorado, Denver;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2022 Category: Research Source Type: clinical trials

Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study
Conditions:   Wheezing;   Asthma in Children Interventions:   Drug: Soy isoflavone;   Drug: matching placebo Sponsors:   Rajesh Kumar;   Northwestern University;   University of South Florida;   University of Colorado, Denver;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 29, 2022 Category: Research Source Type: clinical trials